Explore the 5th Zika Cross-Consortia Newsletter!

May 28, 2019 - The 5th Cross-Consortia Newsletter features the latest advances and publications by the three Zika consortia. You will also learn about the launch of the European Clinical Research Alliance on Infectious Diseases (ECRAID), a new Zika vaccine ... Read more

Practical and Theoretical Course on Arbovirus Diagnostics

March 27, 2019 - Scientists and technicians working on arbovirus projects in Brazil and across Latin America are meeting for a five-day training workshop organized by the Mérieux Foundation (ZikaPLAN) and Fundacao Faculdade de Medicina (ZIKAlliance) on March 25-29, 2019. Read more

Featured Publication

Modelling an optimum vaccination strategy against ZIKA virus for outbreak use

Eduardo Massad et al. – Epidemiology & Infection, May 16, 2019

In this study, the authors present a model to optimise a vaccination campaign aiming to prevent or to curb a Zika virus outbreak. In particular, they aim to determine the optimum time point to introduce a mass vaccination campaign in response to an outbreak, the thresholds to declare an outbreak, the optimum duration of such a strategy and the coverage needed to avert an outbreak.

Read more

Research Focus

NEURO-ZIKA: Neurological Manifestations of Zika

Defining the spectrum of neurological diseases associated with Zika virus (ZIKV) infection, in both the central nervous system (CNS) and peripheral nervous system (PNS) of adults and children.

Read more

WEAR: Wearable Aedes Repellent Technologies

To protect pregnant women, novel, wash-in detergent formulations and long-lasting plastic technologies containing repellents for the treatment of clothing and other wearable repellent technologies are being developed using new microencapsulation techniques.

Read more

Investigating Vaccines in Antibody Dependent Enhancement

Identifying the major T-cell epitopes and cross reactive B-cell epitopes on ZIKV and assessing the role of flavivirus antibodies in protective and pathogenic immunity following ZIKV through antibody dependent enhancement (ADE).

Read more